Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Abstract

This study aimed to investigate the beneficial effects of the oral administration of Lactobacillus brevis FZU0713-fermented Laminaria japonica (FLJ) on lipid metabolism and intestinal microbiota in hyperlipidemic rats fed with a high-fat diet (HFD). The results demonstrated that the oral administration of FLJ significantly inhibited obesity and improved the serum and hepatic biochemical parameters in HFD-fed rats. Histopathological results also indicated that FLJ intervention could significantly reduce the accumulation of lipid droplets in the liver induced by HFD feeding. Furthermore, FLJ intervention up-regulated the fecal short-chain fatty acid (SCFA) levels (mainly acetate, propionate and isobutyrate) in HFD-fed rats. Intestinal microbiota profiling by 16S rRNA gene sequencing revealed that FLJ intervention increased the relative abundance of Akkermansia, Collinsella, Ruminococcaceae_UCG-013, Defluviitaleaceae_UCG-011, Intestinimonas, Actinomyces and Tyzzerella, but decreased the abundance of Flavonifractor, Collinsella, Sporosarcina and Lacticigenium. Based on Spearman's correlation, the fecal levels of TC, TG, acetic acid and butyric acid were positively correlated with the relative abundance of Akkermansia and Ruminococcaceae_NK4A214, but negatively correlated with the relative amount of Flavonifractor and Collinsella. The metabolic function of intestinal microbiota predicted by PICRUSt analysis of 16S rRNA gene sequences demonstrated that primary and secondary bile acid biosyntheses, fatty acid biosynthesis, taurine and hypotaurine metabolism, arachidonic acid metabolism, glycolysis/gluconeogenesis, etc. were significantly down-regulated after 8 weeks of FLJ intervention. Additionally, FLJ intervention significantly regulated the hepatic mRNA levels (including BSEP, CYP7A1, LDLR, HMGCR, CD36 and SREBP1-C) involved in lipid metabolism and bile acid homeostasis. In conclusion, these findings support the possibility that Laminaria japonica fermented with probiotic Lactobacillus has the potential to reduce the disturbance of lipid metabolism by regulating intestinal microflora and liver gene expression profiles, so it can be employed as a potential functional food to prevent hyperlipidemia.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus brevisImproved Abundance of Beneficial BacteriaBeneficial
Moderate
Lactobacillus brevisIncreased Fecal Short-Chain Fatty Acid LevelsBeneficial
Moderate
Lactobacillus brevisReduced Liver Lipid AccumulationBeneficial
Large
Lactobacillus brevisReduced Metabolic Functions of Intestinal MicrobiotaBeneficial
Moderate
Lactobacillus brevisReduced ObesityBeneficial
Large
Lactobacillus brevis HA-112Improved Intestinal Microbial CompositionBeneficial
Large
Lactobacillus brevis HA-112Improved Lipid MetabolismBeneficial
Large
Lactobacillus brevis HA-112Increased Fecal Short-Chain Fatty Acid LevelsBeneficial
Moderate
Lactobacillus brevis HA-112Reduced ObesityBeneficial
Large
Lactobacillus brevis HA-112Regulated Liver Gene ExpressionBeneficial
Large
Lactobacillus brevis Lbr-35Improved Intestinal Microbiota CompositionBeneficial
Moderate
Lactobacillus brevis Lbr-35Increased Short-Chain Fatty Acid LevelsBeneficial
Moderate
Lactobacillus brevis Lbr-35Reduced Liver Lipid AccumulationBeneficial
Large
Lactobacillus brevis Lbr-35Reduced ObesityBeneficial
Large
Lactobacillus brevis MAK11L82BImproved Biochemical ParametersBeneficial
Moderate
Lactobacillus brevis MAK11L82BImproved Microbiota ProfileBeneficial
Moderate
Lactobacillus brevis MAK11L82BIncreased Fecal Short-Chain Fatty AcidsBeneficial
Moderate
Lactobacillus brevis MAK11L82BReduced Hepatic Lipid AccumulationBeneficial
Moderate
Lactobacillus brevis MAK11L82BReduced Metabolic Functions of Intestinal MicrobiotaBeneficial
Moderate
Lactobacillus brevis MAK11L82BReduced ObesityBeneficial
Large
Lactobacillus brevis SD-5214Altered Gut Microbiota CompositionBeneficial
Moderate
Lactobacillus brevis SD-5214Increased Fecal Short-Chain Fatty Acid LevelsBeneficial
Moderate
Lactobacillus brevis SD-5214Reduced Liver Lipid AccumulationBeneficial
Large
Lactobacillus brevis SD-5214Reduced Metabolic Functions of Intestinal MicrobiotaBeneficial
Moderate
Lactobacillus brevis SD-5214Reduced ObesityBeneficial
Large
Lactobacillus brevis UALbr-02Altered Gut Microbiota CompositionBeneficial
Moderate
Lactobacillus brevis UALbr-02Increased Fecal Short-Chain Fatty Acid LevelsBeneficial
Moderate
Lactobacillus brevis UALbr-02Reduced Hepatic Lipid AccumulationBeneficial
Moderate
Lactobacillus brevis UALbr-02Reduced ObesityBeneficial
Large
Lactobacillus brevis VPro 18Altered Gut Microbiota CompositionBeneficial
Moderate
Lactobacillus brevis VPro 18Increased Fecal Short-Chain Fatty Acid LevelsBeneficial
Moderate
Lactobacillus brevis VPro 18Reduced Liver Lipid AccumulationBeneficial
Large
Lactobacillus brevis VPro 18Reduced Metabolic Functions of Intestinal MicrobiotaBeneficial
Moderate
Lactobacillus brevis VPro 18Reduced ObesityBeneficial
Large
Lactobacillus fermentum MAK20L13FAltered Gut Microbiota CompositionBeneficial
Moderate
Lactobacillus fermentum MAK20L13FImproved Lipid MetabolismBeneficial
Large
Lactobacillus fermentum MAK20L13FIncreased SCFA LevelsBeneficial
Moderate
Lactobacillus fermentum MAK20L13FReduced Metabolic FunctionBeneficial
Moderate
Lactobacillus fermentum MAK20L13FReduced ObesityBeneficial
Large
Lactobacillus fermentum MAK20L13FRegulated Liver Gene ExpressionBeneficial
Large
Back to top